Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,517.97
(
0.32%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
-0.89%
)
Bitcoin
73,376.63
(
-0.22%
)
News Focus
News Focus
Post# of 518936
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

georgejjl

Send PM Follow Ignore
Followers 149
Posts 26289
Boards Moderated 0
Alias Born 04/08/2004

georgejjl

Re: georgejjl post# 305420

Wednesday, 03/31/2021 8:21:46 PM

Wednesday, March 31, 2021 8:21:46 PM

Post# of 518936
Expect the Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled 48-week Safety and Efficacy Trial of ANAVEX2-73 for the Treatment of Early Alzheimer's Disease (AD) to complete recruitment by or before the end of April 2021.

Good luck and GOD bless,
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News